Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorChoueiri, T. K.
dc.contributor.authorEto, M.
dc.contributor.authorKopyltsov, E.
dc.contributor.authorRha, S. Y.
dc.contributor.authorPorta, C. G.
dc.contributor.authorMotzer, R.
dc.contributor.authorGruenwald, V.
dc.contributor.authorHutson, T. E.
dc.contributor.authorMendez-Vidal, M. J.
dc.contributor.authorHong, S-H.
dc.contributor.authorWinquist, E.
dc.contributor.authorGoh, J. C. H.
dc.contributor.authorMaroto, P.
dc.contributor.authorBuchler, T.
dc.contributor.authorTakagi, T.
dc.contributor.authorRodriguez-Lopez, K.
dc.contributor.authorXing, D.
dc.contributor.authorSmith, A. D.
dc.contributor.authorPowles, T.
dc.contributor.authoraffiliation[Choueiri, T. K.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
dc.contributor.authoraffiliation[Eto, M.] Kyushu Univ, Dept Urol, Fukuoka, Japan
dc.contributor.authoraffiliation[Kopyltsov, E.] State Inst Healthcare Reg Clin Oncol Dispe, Oncol, Omsk, Russia
dc.contributor.authoraffiliation[Rha, S. Y.] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea
dc.contributor.authoraffiliation[Porta, C. G.] Univ Bari A Moro, Dept Biomed Sci & Human Oncol, Bari, Italy
dc.contributor.authoraffiliation[Motzer, R.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
dc.contributor.authoraffiliation[Gruenwald, V.] Univ Hosp Essen, Clin Med Oncol, Essen, Germany
dc.contributor.authoraffiliation[Gruenwald, V.] Univ Hosp Essen, Urol Clin, Essen, Germany
dc.contributor.authoraffiliation[Hutson, T. E.] Texas Oncol, Med Oncol, Dallas, TX 8 USA
dc.contributor.authoraffiliation[Mendez-Vidal, M. J.] Hosp Univ Reina Sofia, Maimonides Inst Biomed Res Cordoba IMIBIC, Dept Oncol, Cordoba, Spain
dc.contributor.authoraffiliation[Hong, S-H.] Catholic Univ Korea, Seoul St Marys Hosp, Dept Urol, Seoul, South Korea
dc.contributor.authoraffiliation[Winquist, E.] Univ Western Ontario, Dept Oncol, London, ON, Canada
dc.contributor.authoraffiliation[Goh, J. C. H.] ICON Res, South Brisbane, Qld, Australia
dc.contributor.authoraffiliation[Goh, J. C. H.] Univ Queensland, St Lucia, Qld, Australia
dc.contributor.authoraffiliation[Maroto, P.] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Buchler, T.] Charles Univ Prague, Dept Oncol, Prague, Czech Republic
dc.contributor.authoraffiliation[Buchler, T.] Thomayer Univ Hosp, Prague, Czech Republic
dc.contributor.authoraffiliation[Takagi, T.] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan
dc.contributor.authoraffiliation[Rodriguez-Lopez, K.] Merck & Co Inc, Clin Res, Kenilworth, NJ USA
dc.contributor.authoraffiliation[Xing, D.] Eisai Inc, Oncol Business Grp, Biostat, Woodcliff Lake, NJ USA
dc.contributor.authoraffiliation[Smith, A. D.] Eisai Ltd, Clin Res, Hatfield, Herts, England
dc.contributor.authoraffiliation[Powles, T.] Queen Mary Univ London, Barts Canc Inst, London, England
dc.contributor.authoraffiliation[Powles, T.] Queen Mary Univ London, Royal Free Hosp, London, England
dc.contributor.funderEisai Inc., Woodcliff Lake, NJ, USA
dc.contributor.funderMerck Sharp Dohme Corp.
dc.date.accessioned2025-01-07T13:25:41Z
dc.date.available2025-01-07T13:25:41Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.056
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.056
dc.identifier.urihttps://hdl.handle.net/10668/25497
dc.identifier.wosID700527701126
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
dc.page.numberS683-S685
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePhase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía
Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía